E-cigarette use increases addiction risk, study finds.

Aug.10.2022
E-cigarette use increases addiction risk, study finds.
E-cigarette use for smoking cessation increases addiction risk, according to studies by Ohio and Washington universities.

A new study in Cleveland, Ohio suggests that using electronic cigarettes to quit smoking may lead to addiction for users. Similarly, a recent study from the medical school at Washington University in St. Louis found that those who use e-cigarettes to quit smoking are at an increased risk for addiction to both. Researchers said that since e-cigarettes contain nicotine, they are just as addictive as traditional cigarettes.


A new study indicates that smokers who use e-cigarettes to quit smoking are at an increased risk of becoming addicted to both. (AP Photo/Robert F. Bukaty)


This study examined electronic health record data from approximately 112,000 smokers seeking outpatient treatment at a hospital between 2018 and 2020. During the study period, the number of smokers who also started using e-cigarettes doubled, from 0.8% in the first year to over 2% in the second year. About one-fifth of "dual-use" smokers did successfully quit within a year, with slightly higher success rates than those who only smoked cigarettes. However, the study found that about two-thirds of smokers who used both cigarettes and e-cigarettes were still smoking after one year. Dual-use smokers who used traditional smoking cessation methods were more likely to quit.


Statement


This article is compiled from third-party information and is intended solely for industry exchanges and learning.


This article does not represent the views of 2FIRSTS, and 2FIRSTS cannot confirm the truthfulness or accuracy of the content. The translation of this article is only intended for industry communication and research.


Due to limitations in the level of translation, the translated article may not fully convey the original meaning. Please refer to the original article for accuracy.


2FIRSTS maintains complete alignment with the Chinese government on any domestic, Hong Kong, Macau, Taiwan, or foreign-related issues and positions.


Copyright of compiled information belongs to the original media and author. If there is any infringement, please contact us for deletion.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

FDA Says Flavored ENDS Must Show “Added Benefit” as Small Manufacturers Seek Clearer Switching Benchmarks
FDA Says Flavored ENDS Must Show “Added Benefit” as Small Manufacturers Seek Clearer Switching Benchmarks
During the FDA PMTA roundtable session on “Studies of Adult Benefit,” officials said flavored ENDS must demonstrate “added benefit” over tobacco-flavored products under the APPH standard, including sustained complete switching evidence. Small manufacturers questioned switching benchmarks, study duration, and bridging expectations.
Feb.11
Virginia appeals to the Fourth Circuit over partial block on flavored vape ban enforcement
Virginia appeals to the Fourth Circuit over partial block on flavored vape ban enforcement
Virginia has asked the Fourth Circuit to overturn a district court order that partially blocked enforcement of the commonwealth’s flavored vape ban. In a notice, the state told U.S. District Judge David J. Novak it seeks to upend his December ruling that Virginia’s Chapter 23.2 statute is preempted by the Food, Drug and Cosmetic Act and the Family Smoking Prevention and Tobacco Control Act.
Jan.12 by 2FIRSTS.ai
Russia’s Volgograd Police Seize Illicit Nicotine Products Worth Over US$42.9K+
Russia’s Volgograd Police Seize Illicit Nicotine Products Worth Over US$42.9K+
Police in Russia’s Volgograd region say they seized nicotine products lacking mandatory markings valued at more than RUB 3.3 million (about US$42,900+, using RUB 1 = US$0.013). A 43-year-old suspect allegedly stored and sold the products through two retail outlets in Volgograd’s Central and Dzerzhinsky districts. A criminal case has been opened under Article 171.1(6) of the Russian Criminal Code.
Jan.30 by 2FIRSTS.ai
South Dakota Senate Committee Advances Bill Tightening Nicotine Retail Rules
South Dakota Senate Committee Advances Bill Tightening Nicotine Retail Rules
South Dakota Senate Bill 221 (SB 221), which seeks to regulate the retail sale of nicotine products, has passed the Senate Health and Human Services Committee with a unanimous 7–0 recommendation. The bill was significantly amended, expanding from three to nine pages and shifting its focus from vapor products alone to all nicotine products.
Regulations
Feb.22
Thai Customs Region 2 seizes 22,800 YOOZ-branded vape pod heads
Thai Customs Region 2 seizes 22,800 YOOZ-branded vape pod heads
Thailand’s Customs Region 2 searched a private logistics company in Mukdahan province and seized 22,800 vape pod heads with no evidence of customs clearance. The seized items weighed 389.50 kg in total and were valued at more than THB 4.5 million (about USD 143,581.90). The photo shows packaging marked “YOOZ”.
Jan.16 by 2FIRSTS.ai
FDA Outlines Manufacturing Requirements as Critical to ENDS PMTA Success
FDA Outlines Manufacturing Requirements as Critical to ENDS PMTA Success
FDA officials said manufacturing consistency is a core prerequisite for ENDS PMTA reviews, not a procedural formality. During its February 10, 2026 roundtable, the agency outlined expectations for quality management systems, manufacturing documentation, nicotine control, stability studies, and risk mitigation, emphasizing that robust manufacturing evidence underpins determinations of whether products are appropriate for the protection of public health.
Feb.11